| UPSA Switzerland AG - Dafalgan DOLO 500 mg, Brausetabletten | | 69265 | | 01 | | Dafalgan DOLO 500 mg | | Brausetabletten | | N02BE01 | | Paracetamol | | 01.05.2024 | | |
| | Composition | | paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, natrii docusas, povidonum K 30, sorbitolum 300 mg, saccharinum natricum, E 211 60.606 mg, pro compresso corresp. natrium 412.3 mg. | | Packungsbestandteile | | comprimés effervescents | | | | Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | E 211 | 60.606 mg | conserv. | | Sodium Carbonate | | | | Natrii Docusas | | | | Sodium Hydrogenocarbonate | | | | Povidonum K | 30 | | | Pro Compresso | | | | Saccharinum Natricum | | | | Sorbitol | 300 mg | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 16 | DDP | DDP | D | | Non |
|
|
